How many milligrams of Trelagliptin is best to take at one time and analysis of medication recommendations

Trelagliptin (Trelagliptin) is a new dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor), mainly used for blood sugar control in patients with type 2 diabetes (T2DM). Its mechanism of action is to inhibit the enzyme activity of DPP-4, prolong the action time of glucagon-like peptide-1 (GLP-1) in the body, promote insulin secretion and inhibit glucagon release, thereby reducing postprandial and fasting blood glucose levels. The long half-life of trolagliptin allows it to be taken once a week, simplifying the medication regimen and improving patient compliance.

Clinical studies have shown that trolagliptin can achieve the best efficacy after taking 100mg once. This dose can significantly reduce glycated hemoglobin (HbA1c) levels in most patients with type 2 diabetes, while improving fasting blood sugar and postprandial blood sugar fluctuations. Since the drug is a long-acting preparation, the blood concentration remains stable within a week, thus ensuring continuous blood sugar control. Patients should swallow the tablet whole when taking it. It can be taken with food or on an empty stomach. However, it is not recommended to chew it to ensure that the sustained-release properties of the drug are not destroyed.

For special groups, such as patients with mild to moderate impairment of renal function, there is usually no need to adjust the dosage, but blood glucose and renal function monitoring should be performed under the guidance of a physician. There is less experience with patients with severe renal insufficiency or dialysis, and treatment options should be carefully considered or adjusted. Elderly patients also need to pay attention to monitoring the risk of hypoglycemia and changes in renal function due to reduced body metabolism. In general, trotagliptin has good tolerance and safety, with a low incidence of adverse reactions. Common mild side effects include headache, upper respiratory tract infection and gastrointestinal discomfort.

In terms of medication recommendations, trolagliptin should be used as part of the basic hypoglycemic treatment plan, and can be used alone or in combination with metformin or sulfonylureas. Patients should insist on taking medication at a fixed time every week, combined with a reasonable diet and moderate exercise to achieve optimal blood sugar control. Regular monitoring of blood sugar and HbA1c levels will help evaluate the efficacy and adjust the treatment plan in a timely manner. Scientific use of trolagliptin can not only significantly improve blood sugar indicators, but also reduce medication burden and improve long-term compliance and quality of life.

Reference link:https://www.drugs.com